1 / 16

Group B Streptococcus

Group B Streptococcus. Streptococcus agalactiae. GBS Epidemiology. Colonizes the genital tract; risk groups include: Infants: Colonization during delivery may results in invasive disease Pregnant and post-partum women Non-pregnant adults Elderly

Mia_John
Download Presentation

Group B Streptococcus

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Group B Streptococcus Streptococcus agalactiae

  2. GBS Epidemiology • Colonizes the genital tract; risk groups include: • Infants: Colonization during delivery may results in invasive disease • Pregnant and post-partum women • Non-pregnant adults • Elderly • Individuals with chronic underlying disease

  3. Burden of Invasive GBS Disease, 1989-1990, AtlantaNEJM, 1993; 328:1807

  4. Age Distribution of GBS in Infants and NeonatesClin Microbiol Rev, 1998; 11:497.

  5. Incidence of Invasive GBS Disease with Age, 1989-1990, AtlantaNEJM, 1993; 328:1807

  6. Risk Factors for Early Onset Group B Streptococcal DiseaseBMJ, 2002; 325:308

  7. Prenatal GBS screening at 35-37 weeks: Offer penicillin intrapartum if: GBS (+) Culture not done and risk factors present Previous infant had IGBS disease Mother had GBS bacteriuria, this pregnancy Delivery occurred at < 37 weeks gestation Risk factor screening: Offer penicillin intrapartum if: Previous infant had IGBS disease Mother had GBS bacteriuria, this pregnancy Delivery occurred at < 37 weeks gestation Duration of ruptured membranes > 18 hours Intrapartum temperature > 100.4F 1996 Recommendations (CDC)MMWR, 1996; 45(No. RR-7)

  8. Reduction in IGBS Disease Emerg Infect Dis, 2001; 7:92

  9. Population-based Comparison of Strategies to Prevent Early-Onset GBSNEJM, 2002; 347:233

  10. 2002 Recommendations (CDC)MMWR, 2002; 51(No. RR-11) • Universal screening of all women at 35-37 weeks gestation • Prophylax: • Previous infant with IGBS • GBS bacteriuria this pregnancy • Positive GBS screen this pregnancy unless • C-section planned in the absence of labor or rupture of membranes • Unknown GBS status AND delivery at < 37 weeks, rupture of membranes > 18 hours, or intrapartum temperature > 100.4 F

  11. VaccineArch Dis Child, 2003; 88:375-8 • Phase I trial completed • Women at 32-34 weeks • Serum antibody and cord blood antibody • Elevated after immunization • Promoted killing of GBS in vitro • May protect against both late and early onset disease • Barriers • Pharmaceutical leadership / liability issues

  12. GBS Clinical Presentation • Neonates • Sepsis, meningitis, pneumonia, cellulitis, osteomyelitis, septic arthritis • Pregnant and post-partum women • Mild UTI, sepsis; less commonly osteomyelitis, endocarditis, meningitis • Non-pregnant adults • Bacteremia, skin or soft tissue infections > pneumonia > urosepsis > endocarditis > peritonitis > meningitis > empyema

  13. IGBS Case Definition (draft) • Clinical description • Invasive group B streptococcal infections may manifest as any of several clinical syndromes, including pneumonia, deep soft-tissue infection, meningitis, peritonitis, osteomyelitis, septic arthritis, postpartum sepsis (i.e., puerperal fever), neonatal sepsis, and nonfocal bacteremia.

  14. IGBS Case Definition (draft) • Laboratory criteria for diagnosis • Isolation of group B Streptococcus (Streptococcus agalactiae) by culture from a normally sterile site (e.g., blood or cerebrospinal fluid, or, less commonly, joint, pleural, or pericardial fluid) • Case classification • Confirmed: a case that is laboratory confirmed

  15. Public Health Action • Case ascertainment • Case investigation: • Fill out yellow card and CDC meningitis form • Follow up early onset disease (onset < 7 days of age) to determine if mother was cultured/prophylaxed.

  16. GBS - Summary • Important pathogen of: • Newborns • Pregnant and post-partum women • Non-pregnant adults with underlying disease • Vaccine in development • Investigation • Demographics, site of infection, source of isolate (establish baseline incidence before vaccine licensure) • Follow-up of early-onset disease

More Related